Gilead Sciences (GILD) reported $7.57 billion in revenue for the quarter ended December 2024, representing a year-over-year increase of 6.4%. EPS of $1.90 for the same period compares to $1.72 a year ...
Q4 2024 Management View CEO Lance Rosenzweig highlighted 2024 as a transformative year for Pitney Bowes, emphasizing progress on four strategic initiatives: exiting the Global Ecommerce (GEC) segment, ...